EluPro™ 66BE02-100Recalls & reported problems
Boston Scientific Corporation · Antibiotic-Eluting BioEnvelope · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00802526630002), received between Aug 9, 2026 and Sep 25, 2026 — classified as 4 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
Patient problems
- Unspecified Infection3
- Bacterial Infection1
- Hypersensitivity/Allergic reaction1
- Purulent Discharge1
- Sepsis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjurySep 25, 2026Adverse Event Without Identified Device or Use Problem
It was reported that this bioenvelope was part of a system revision due to infection. There was no additional adverse patient effects reported. The bioenvelope was explanted.
Patient problems: Unspecified Infection
MAUDE report 50897251 ↗InjurySep 17, 2026Adverse Event Without Identified Device or Use Problem
It was reported that this bioenvelope was part of a system revision due to infection. There were no additional adverse patient effects reported. The bioenvelope was explanted.
Patient problems: Unspecified Infection
MAUDE report 50807989 ↗InjurySep 16, 2026Adverse Event Without Identified Device or Use Problem
Patient problems: Unspecified Infection
MAUDE report 50793372 ↗InjuryAug 9, 2026Adverse Event Without Identified Device or Use Problem
It was reported that this bio-envelope was part of the system revision due to bacterial infection and sepsis. Reportedly, the implant pocket had oozing bloody purulent discharge. The bacterial culture was negative but there was no confirmation of the possible reaction to the bio-envelope. No adverse patient effects were reported. The bio-envelope was explanted.
Patient problems: Bacterial Infection; Hypersensitivity/Allergic reaction; Purulent Discharge; Sepsis
MAUDE report 50188147 ↗
Other Mesh, surgical devices
- Peri-Guard PC1016NSynovis Life Technologies, Inc. · Mesh, surgical1 recall1 report
- MEDPOR TITAN 81032Stryker Leibinger GmbH & Co. KG · Mesh, surgical1 recall1 report
- SurgiMend® 606-300-006Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-300-019Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-400-009Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-300-020Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-003-001Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-003-002Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page